Learn More
Medchemexpress LLC Minodronic acid | 180064-38-4 | 99.67% | 322.15 | 5 MG

Supplier: Medchemexpress LLC HY163225MG
Minodronic acid is an FPP synthase inhibitor with an IC50 of 3 nM and an antagonist of P2X2/3 receptors with an IC50 of 62.7 μM. It induces tumor cell apoptosis, inhibits cell growth, and suppresses bone resorption. It can be used in research related to osteoporosis and cancer, inhibiting proliferation in human bladder cancer cell lines and osteoclast-mediated bone resorption.
- Inhibits FPP synthase
- Antagonizes P2X2/3 receptors
- Induces tumor cell apoptosis
- Inhibits cell growth
- Suppresses bone resorption
- White to off-white solid appearance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.